Alzheimer's disease amyloid β-protein and synaptic function

Philosophical transactions of the Royal Society of London. B

Press, H. (1886) · Cited by 10,087 · see citing works

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,865 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · see citing works

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Long-Term Potentiation and Memory

Lynch, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 2,001 · see citing works

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,677 · see citing works

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · see citing works

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627 · see citing works

Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · see citing works

Regulation of NMDA receptor trafficking by amyloid-β

Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · see citing works

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers

Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560 · see citing works

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · see citing works

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · see citing works

Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · see citing works

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · cited 2× · see citing works

Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease

Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125 · see citing works

AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss

Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042 · see citing works

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake

Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972 · see citing works

Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695

Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · see citing works

Cholinergic systems in mammalian brain and spinal cord

WOOLF, N. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90006-m · Cited by 948 · see citing works

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease

HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938 · see citing works

Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · see citing works

β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity

Wang, H.-Y., Lee, D. H. S., D’Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 818 · see citing works

Metabotropic glutamate receptors: electrophysiological properties and role in plasticity

Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 776 · see citing works

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00089-3 · Cited by 751 · see citing works

Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · see citing works

Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice

Kuchibhotla, K. V., Lattarulo, C. R., Hyman, B. T., & Bacskai, B. J. (2009) · Science · doi:10.1126/science.1169096 · Cited by 729 · see citing works

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse

Parsons, C. G., Stöffler, A., & Danysz, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.013 · Cited by 701 · see citing works

β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

Zheng, H., Jiang, M., Trumbauer, M. E., SIRINATHSINGHJI, D. J. S., Hopkins, R., Smith, D. W., HEAVENS, R. P., Dawson, G. R., Boyce, S., Conner, M. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90073-x · Cited by 699 · see citing works

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

Bodick, N. C., Offen, W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 687 · see citing works

Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies

Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 669 · see citing works

β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

Koh, J., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617 · see citing works

The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging

Wang, J., Dickson, D. W., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7085 · Cited by 567 · see citing works

Globular amyloid β‐peptide ₁₋₄₂ oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559 · see citing works

Nature Reviews Neuroscience

(2019) · Nature reviews. Neuroscience · doi:10.1038/41583.1471-0048 · Cited by 550 · see citing works

The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease

Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 531 · see citing works

Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction

Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 524 · see citing works

Synaptic degeneration in Alzheimer's disease

Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · see citing works

Excitatory amino acids and Alzheimer's disease

Greenamyre, J. T., & Young, A. B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90143-7 · Cited by 482 · see citing works

Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory

Morris, R., Moser, E. I., Riedel, G., Martin, S. J., Sandin, J., Day, M., & O’Carroll, C. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2002.1264 · Cited by 480 · see citing works

β-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal α7 Nicotinic Acetylcholine Receptors:<i>In Vitro</i>and<i>In Vivo</i>Mechanisms Related to Alzheimer's Disease

Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462 · see citing works

Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal

Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439 · cited 2× · see citing works

Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5

Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437 · see citing works

Properties of Neuronal Nicotinic Acetylcholine Receptors: Pharmacological Characterization and Modulation of Synaptic Function,

Albuquerque, E. X., Alkondon, M., Pereira, E. F. R., Castro, N. G., Schrattenholz, A. S., Barbosa, C. T. F., Bonfante-Cabarcas, R. A., Aracava, Y., Eisenberg, H. M., & Maelicke, A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36503-6 · Cited by 436 · see citing works

Timing and Location of Nicotinic Activity Enhances or Depresses Hippocampal Synaptic Plasticity

Ji, D., Lape, R., & Dani, J. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00332-4 · Cited by 419 · see citing works

Effects of nicotinic stimulation on cognitive performance

NEWHOUSE, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 401 · see citing works

Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses

Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397 · see citing works

The Secreted β-Amyloid Precursor Protein Ectodomain APPsα Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice

Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A., Herms, J., Buchholz, C., Eckman, C. B., Korte, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1026-07.2007 · Cited by 390 · see citing works

Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein

Dawson, G. R., Seabrook, G. R., Zheng, H., Smith, D. W., Graham, S. J., O'Dowd, G., Bowery, B. J., Boyce, S., Trumbauer, M. E., Chen, H. Y., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00410-2 · Cited by 364 · see citing works

Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

Klyubin, I., Betts, V., Welzel, A. T., Blennow, K., Zetterberg, H., Wallin, A., Lemere, C. A., Cullen, W. K., Peng, Y., Wisniewski, T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5161-07.2008 · Cited by 321 · see citing works

Behavioral and anatomical deficits in mice homozygous for a modified ?-amyloid precursor protein gene

Müller, U. (1994) · Cell · doi:10.1016/0092-8674(94)90066-3 · Cited by 308 · see citing works

Decoding NMDA Receptor Signaling: Identification of Genomic Programs Specifying Neuronal Survival and Death

Zhang, S.-J., Steijaert, M. N., Lau, D., Schütz, G., Delucinge-Vivier, C., Descombes, P., & Bading, H. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.025 · Cited by 304 · see citing works

Correlation between Scores for Dementia and Counts of ‘Senile Plaques’ in Cerebral Grey Matter of Elderly Subjects

ROTH, M., TOMLINSON, B. E., & BLESSED, G. (1966) · Nature · doi:10.1038/209109a0 · Cited by 298 · see citing works

The Pathogenesis of Alzheimer Disease: An Alternative to the Amyloid Hypothesis

Terry, R. D. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199655100-00001 · Cited by 291 · see citing works

β-Amyloid 1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice

Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 291 · see citing works

Soluble β-Amyloid1-40Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses

Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M. A., & Almeida, O. F. X. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 276 · see citing works

β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis

Harkany, T., Ábrahám, I. M., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C. J., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 275 · see citing works

Mg²⁺Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine

Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271 · see citing works

Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia

Nordberg, A. K., Alafuzoff, I. I., & Winblad, B. G. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310115 · Cited by 270 · see citing works

β-Amyloid protein-induced Alzheimer's disease animal model

Nitta, A., Itoh, A., Hasegawa, T., & Nabeshima, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90239-9 · Cited by 266 · see citing works

Pathologically activated therapeutics for neuroprotection

Lipton, S. A. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2229 · Cited by 259 · see citing works

Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors

Léveillé, F., Gaamouch, F. E., Gouix, E., Lecocq, M., Lobner, D., Nicole, O., & Buisson, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-107268 · Cited by 258 · see citing works

Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein

Seabrook, G. R., Smith, D. W., Bowery, B. J., Easter, A., Reynolds, T., Fitzjohn, S. M., Morton, R. A., Zheng, H., Dawson, G. R., SIRINATHSINGHJI, D. J. S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00204-4 · Cited by 256 · see citing works

Excitatory amino acids

Moloney, M. G. (1998) · Natural Product Reports · doi:10.1039/a815205y · Cited by 255 · see citing works

The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons

Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 248 · see citing works

Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

Jones, C. K., Brady, A. E., Davis, A. A., Xiang, Z., Bubser, M., Tantawy, M. N., Kane, A. S., Bridges, T. M., Kennedy, J. P., Bradley, S. R., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-08.2008 · Cited by 248 · see citing works

Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine

Kenney, J. W., & Gould, T. J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8037-9 · Cited by 242 · see citing works

β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes

Dineley, K. T., Bell, K. A., Bui, D., & Sweatt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200066200 · Cited by 241 · see citing works

β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons

Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 240 · see citing works

Modulation of Synaptic Plasticity by Physiological Activation of M1Muscarinic Acetylcholine Receptors in the Mouse Hippocampus

Shinoe, T., Matsui, M., Taketo, M. M., & Manabe, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2338-05.2005 · Cited by 237 · see citing works

Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments

Cullen, W. K., Suh, Y., Anwyl, R., & Rowan, M. J. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00006 · Cited by 235 · see citing works

Nicotinic receptor abnormalities in Alzheimer’s disease

COURT, J. A., Martin-Ruiz, C. M., Piggott, M. A., Spurden, D., Griffiths, M., & Perry, E. K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01116-1 · Cited by 232 · see citing works

A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses

Deshpande, A., Kawai, H., Metherate, R., Glabe, C. G., & Busciglio, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5980-08.2009 · Cited by 232 · see citing works

Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits

Stéphan, A., Laroche, S., & Davis, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05703.2001 · Cited by 225 · see citing works

Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades

Matos, M., Augusto, E., Oliveira, C. R., & Agostinho, P. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.022 · Cited by 223 · see citing works

Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity

Kang, J.-E., Cirrito, J. R., Dong, H., Csernansky, J. G., & Holtzman, D. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700148104 · Cited by 219 · see citing works

Adult-derived neural precursors transplanted into multiple regions in the adult brain

Herrera, D. G., García‐Verdugo, J. M., & Álvarez-Buylla, A. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6 · Cited by 204 · see citing works

Endogenous secreted amyloid precursor protein-α regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory

Taylor, C. J., Ireland, D. R., Ballagh, I. H., Bourne, K., Marechal, N. M., Turner, P. R., Bilkey, D. K., Tate, W. P., & Abraham, W. C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.011 · Cited by 204 · see citing works

Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease

Geula, C., Nagykery, N. G., Nicholas, A., & Wu, C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1df3 · Cited by 203 · see citing works

Synaptic plasticity in animal models of early Alzheimer's disease

Rowan, M. J., Klyubin, I. V., Cullen, W. K., & Anwyl, R. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2002.1240 · Cited by 202 · see citing works

Hippocampal α7 and α4β2 nicotinic receptors and working memory

Levin, E. D., Bradley, A., Addy, N., & Sigurani, N. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00538-3 · Cited by 202 · see citing works

Acute and chronic nicotine exposure differentially facilitate the induction of LTP

Fujii, S., Ji, Z., Morita, N., & Sumikawa, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01982-4 · Cited by 200 · see citing works

Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 200 · see citing works

Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease

Dziewczapolski, G., Głogowski, M., Masliah, E., & Heinemann, S. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6159-08.2009 · Cited by 197 · see citing works

Use-Dependent Effects of Amyloidogenic Fragments of β-Amyloid Precursor Protein on Synaptic Plasticity in Rat HippocampusIn Vivo

Kim, J., Anwyl, R., Suh, Y., Djamgoz, M. B. A., & Rowan, M. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01327.2001 · Cited by 182 · see citing works

RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?

Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1030 · Cited by 179 · see citing works

Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices

Ishida, A., Furukawa, K., Keller, J. N., & Mattson, M. P. (1997) · Neuroreport · doi:10.1097/00001756-199707070-00009 · Cited by 178 · see citing works

β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution

Gu, Z., Liu, W., & Yan, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806508200 · Cited by 178 · see citing works

Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus

Chen, Q.-S., Wei, W., Shimahara, T., & Xie, C.-W. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4034 · Cited by 176 · see citing works

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Biton, B., Bergis, O. E., Galli, F., Alain, N., Lochead, A. W., Jegham, S., Godet, D., Lanneau, C., Santamaria, R., Chesney, F., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301189 · Cited by 174 · see citing works

Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetes a

Lorenzo, A., & Yankner, B. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34406.x · Cited by 162 · see citing works

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein

Wevers, A., Monteggia, L. M., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J. M., Pereira, E. F. R., Eisenberg, H. M., Giacobini, E., de Vos, R. A. I., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00676.x · Cited by 158 · see citing works

Low-frequency activation of the NMDA receptor system can prevent the induction of LTP

Coan, E. J., Irving, A. J., & Collingridge, G. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90038-4 · Cited by 157 · see citing works

Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction

Rowan, M. J., Klyubin, I. V., Wang, Q., Hu, N., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 152 · see citing works

Activation of nicotinic acetylcholine receptors induces long‐term potentiation in vivo in the intact mouse dentate gyrus

Matsuyama, S., Matsumoto, A., Enomoto, T., & Nishizaki, T. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00259.x · Cited by 143 · see citing works

Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 143 · see citing works

Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model

Cacucci, F., Yi, M., Wills, T. J., Chapman, P. F., & O'Keefe, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802908105 · Cited by 142 · see citing works

Effects of memantine and MK‐801 on NMDA‐induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

Frankiewicz, T., Potier, B., Bashir, Z. I., Collingridge, G. L., & Parsons, C. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15245.x · Cited by 135 · see citing works

The role of nicotinic acetylcholine receptors in Alzheimer’s disease

Oddo, S., & LaFerla, F. M. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.080 · Cited by 132 · see citing works

Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment

Yang, T., Knowles, J. K., Lu, Q., Zhang, H., Arancio, O., Moore, L. A., Chang, T., Wang, Q., Andreasson, K. I., Rajadas, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003604 · Cited by 130 · see citing works

β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus

Wu, J., Anwyl, R., & Rowan, M. J. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00031 · Cited by 128 · see citing works

Nicotinic Acetylcholine Receptors at Glutamate Synapses Facilitate Long-Term Depression or Potentiation

Ge, S., & Dani, J. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0542-05.2005 · Cited by 125 · see citing works

Chronic Psychosocial Stress Exacerbates Impairment of Cognition and Long-Term Potentiation in β-Amyloid Rat Model of Alzheimer's Disease

Srivareerat, M., Tran, T. T., Alzoubi, K. H., & Alkadhi, K. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.021 · Cited by 122 · see citing works

Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease

Srivareerat, M., Tran, T. T., Salim, S., Aleisa, A. M., & Alkadhi, K. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.015 · Cited by 121 · see citing works

Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity

Ma, H., Lesné, S., Kotilinek, L., Steidl-Nichols, J. V., Sherman, M. A., Younkin, L. H., Younkin, S. G., Forster, C. L., Sergeant, N., Delacourte, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609521104 · Cited by 121 · see citing works

Nicotinic receptor‐mediated enhancement of long‐term potentiation involves activation of metabotropic glutamate receptors and ryanodine‐sensitive calcium stores in the dentate gyrus

Welsby, P. J., Rowan, M. J., & Anwyl, R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05187.x · Cited by 118 · see citing works

Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo

Klyubin, I. V., Walsh, D. M., Cullen, W. K., Fadeeva, J. V., Anwyl, R., Selkoe, D. J., & Rowan, M. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03389.x · Cited by 115 · see citing works

No hippocampal neuron or synaptic bouton loss in learning-impaired aged β-Amyloid precursor protein-null mice

Phinney, A. L., Calhoun, M. E., Wolfer, D. P., Lipp, H., Zheng, H., & Jucker, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00645-9 · Cited by 114 · see citing works

BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus

Wang, H., Song, L., Laird, F. M., Wong, P. C., & Lee, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2440-08.2008 · Cited by 114 · see citing works

Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease

Verdier, Y., & Penke, B. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043486937 · Cited by 114 · see citing works

β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimerʼs disease

Harris‐White, M. E., Carney, J. M., Cole, P. S., Hensley, K., Howard, B. J., Martin, L., Bummer, P. M., Wang, Y., Pedigo, N. W., & Butterfield, D. A. (1995) · Neuroreport · doi:10.1097/00001756-199510020-00013 · Cited by 112 · see citing works

Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP

Zajaczkowski, W., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00070-1 · Cited by 110 · see citing works

Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice

Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.011 · Cited by 109 · see citing works

α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in β-amyloid infused rats

Chen, L., Yamada, K., Nabeshima, T., & Sokabe, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.09.018 · Cited by 109 · see citing works

Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning

Sénéchal, Y., Kelly, P. H., & Dev, K. K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.003 · Cited by 105 · see citing works

Long-Term Potentiation Is Increased in the CA1 Area of the Hippocampus of APPswe/ind CRND8 Mice

Jolas, T. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0557 · Cited by 99 · see citing works

NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus

Raymond, C. R., Ireland, D. R., & Abraham, W. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02269-8 · Cited by 94 · see citing works

Role of Amyloid- Glycine 33 in Oligomerization, Toxicity, and Neuronal Plasticity

Harmeier, A., Wozny, C., Rost, B. R., Munter, L. M., Hua, H., Georgiev, O., Beyermann, M., Hildebrand, P. W., Weise, C., Schaffner, W., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1336-09.2009 · Cited by 94 · see citing works

Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease

Bishop, G. M., & Robinson, S. R. (2004) · Drugs &amp; Aging · doi:10.2165/00002512-200421100-00001 · Cited by 94 · see citing works

Amyloid 1-42 peptide alters the gating of human and mouse -bungarotoxin-sensitive nicotinic receptors

Grassi, F., Palma, E., Tonini, R., Amici, M., Ballivet, M., & Eusebi, F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.035436 · Cited by 93 · see citing works

β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices

Arias, C., Arrieta, I., & Tapia, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410416 · Cited by 93 · see citing works

Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory

Bancroft, A., & Levin, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00099-x · Cited by 89 · see citing works

Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approaches

Wevers, A., Burghaus, L., Moser, N., Witter, B., Steinlein, O. K., Schütz, U., Achnitz, B., Krempel, U., Nowacki, S., Pilz, K., et al. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00215-1 · Cited by 86 · see citing works

Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?

Small, D. H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.006 · Cited by 85 · see citing works

Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties

Tietje, K. R., Anderson, D. J., Bitner, R. S., Blomme, E. A. G., Brackemeyer, P. J., Briggs, C. A., Browman, K. E., Bury, D., Curzon, P., Drescher, K. U., et al. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00037.x · Cited by 85 · see citing works

Soluble amyloid- peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo

Hu, N., Smith, I. M., Walsh, D. M., & Rowan, M. J. (2008) · Brain · doi:10.1093/brain/awn174 · Cited by 84 · see citing works

β-amyloid-(1–40) increases long-term potentiation in rat hippocampus in vitro

Wu, J., Anwyl, R., & Rowan, M. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00539-w · Cited by 80 · see citing works

Effects of an exogenous β-amyloid peptide on retention for spatial learning

McDonald, M. P., Dahl, E. E., Overmier, J. B., Mantyh, P. W., & Cleary, J. P. (1994) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(05)80059-7 · Cited by 80 · see citing works

β-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism

Fernández-Tomé, P., Brera, B., Arévalo, M., & CEBALLOS, M. L. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.006 · Cited by 79 · see citing works

Novel modulatory mechanisms revealed by the sustained application of nicotine in the guinea‐pig hippocampus in vitro

Mann, E. O., & Greenfield, S. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.045492 · Cited by 79 · see citing works

Nicotinic Acetylcholine Receptors

Wiley, J., York, N., Colquhoun, D., Unwin, P. N. T., Shelley, C., Hatton, C., & Sivilotti, L. G. (2004) · Encyclopedic Dictionary of Genetics, Genomics and Proteomics · doi:10.1002/0471684228.egp08474 · Cited by 79 · see citing works

Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones

Ramsden, M., Plant, L. D., Webster, N. J., Vaughan, P. F. T., Henderson, Z., & Pearson, H. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00618.x · Cited by 76 · see citing works

α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity

Wright, S., Malinin, N. L., Powell, K. A., Yednock, T. A., Rydel, R. E., & Griswold‐Prenner, I. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.002 · Cited by 75 · see citing works

α7‐Nicotinic acetylcholine receptors mediate an Aβ1−42‐induced increase in the level of acetylcholinesterase in primary cortical neurones

Fodero, L. R., Mok, S. S., Lošić, D., Martin, L. L., Aguilar, M., Barrow, C. J., Livett, B. G., & Small, D. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02296.x · Cited by 75 · see citing works

Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-d-aspartate (NMDA) versus non-NMDA receptor/channel activation

Ye, C., Walsh, D. M., Selkoe, D. J., & Hartley, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.060 · Cited by 75 · see citing works

Bridging Physiology and Pathology in AD

Kim, D., & Tsai, L. (2009) · Cell · doi:10.1016/j.cell.2009.05.042 · Cited by 72 · see citing works

Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors

Abbott, J. J., Howlett, D. R., Francis, P. T., & Williams, R. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.003 · Cited by 71 · see citing works

Effects of β-Amyloid-(25-35) Peptides on Radioligand Binding to Excitatory Amino Acid Receptors and Voltage-Dependent Calcium Channels: Evidence for a Selective Affinity for the Glutamate and Glycine Recognition Sites of the NMDA Receptor

Cowburn, R. F., Wiehager, B., Trief, E., Mo, L., & Sundström, E. (1997) · Neurochemical Research · doi:10.1023/a:1021942109490 · Cited by 71 · see citing works

Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine

Klyubin, I., Wang, Q., Reed, M. N., Irving, E. A., Upton, N., Hofmeister, J., Cleary, J. P., Anwyl, R., & Rowan, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.005 · Cited by 69 · cited 5× · see citing works

Differential physiologic responses of α7 nicotinic acetylcholine receptors to β‐amyloid1–40 and β‐amyloid1–42

Lee, D. H. S., & Wang, H.-Y. (2003) · Journal of Neurobiology · doi:10.1002/neu.10203 · Cited by 67 · see citing works

Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease.

Warpman, U., Alafuzoff, I., & Nordberg, A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90103-r · Cited by 67 · see citing works

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane

Bymaster, F. P., Shannon, H. E., Rasmussen, K., DeLapp, N. W., Mitch, C. H., Ward, J. S., Calligaro, D. O., Ludvigsen, T. S., Sheardown, M. J., Olesen, P. H., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00487-7 · Cited by 65 · see citing works

β-Amyloid produces a delayed NMDA receptor- dependent reduction in synaptic transmission in rat hippocampus

Cullen, W. K., Wu, J., Anwyl, R., & Rowan, M. J. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00018 · Cited by 65 · see citing works

Compartmentalized NMDA receptor signalling to survival and death

Soriano, F. X., & Hardingham, G. E. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.138875 · Cited by 65 · see citing works

Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus

Welsby, P. J., Rowan, M. J., & Anwyl, R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06562.x · Cited by 64 · see citing works

Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?

LAWLOR, B. A., & Davis, K. L. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90227-q · Cited by 63 · see citing works

The cholinergic neuronal phenotype in alzheimer′s disease

Blusztajn, J. K., & Berse, B. (2000) · Metabolic Brain Disease · doi:10.1007/bf02680013 · Cited by 62 · see citing works

Amyloid β‐protein fragments 25–35 and 31–35 potentiate long‐term depression in hippocampal CA1 region of rats in vivo

Cheng, L., Yin, W., Zhang, J., & Qi, J. (2008) · Synapse · doi:10.1002/syn.20599 · Cited by 62 · see citing works

Nicotinic receptors and Alzheimer's disease

Bourin, M., Ripoll, N., & Dailly, É. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001631 · Cited by 61 · see citing works

Nicotinic receptor agonists and antagonists increase sAPPα secretion and decrease Aβ levels in vitro

Mousavi, M. T., & Hellström‐Lindahl, E. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.001 · Cited by 60 · see citing works

Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo

Molnár, Z., Soós, K., Lengyel, I., Penke, B., Szegedi, V., & Budai, D. (2004) · Neuroreport · doi:10.1097/01.wnr.0000134471.06244.d2 · Cited by 60 · see citing works

High content screen microscopy analysis of Aβ1–42-induced neurite outgrowth reduction in rat primary cortical neurons: Neuroprotective effects of α7 neuronal nicotinic acetylcholine receptor ligands

Hu, M., Schurdak, M. E., Puttfarcken, P. S., Kouhen, R. E., Gopalakrishnan, M., & Li, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.051 · Cited by 58 · see citing works

Toxicity of β-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-d-aspartate receptor subunits

Domingues, A. M. D. J., Almeida, S., DACRUZESILVA, E., Oliveira, C. R., & Rego, A. C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.001 · Cited by 58 · see citing works

Chapter 12 Modulation of LTP induction by NMDA receptor activation and nitric oxide release

Zorumski, C. F., & Izumi, Y. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63207-0 · Cited by 57 · see citing works

Cognitive dysfunction induced by sequential injection of amyloid-β and ibotenate into the bilateral hippocampus; protection by memantine and MK-801

Nakamura, S., Murayama, N., Noshita, T., Katsuragi, R., & Ohno, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.049 · Cited by 57 · see citing works

Nicotinic Receptors Differentially Regulate N-Methyl-d-aspartate Damage in Acute Hippocampal Slices

Ferchmin, P. A., Pérez, D., Eterović, V. A., & de Vellis, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.048173 · Cited by 57 · see citing works

Amyloid β Protein Modulates Glutamate-Mediated Neurotransmission in the Rat Basal Forebrain: Involvement of Presynaptic Neuronal Nicotinic Acetylcholine and Metabotropic Glutamate Receptors

Chin, J. H., Ma, L., MacTavish, D., & Jhamandas, J. H. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1843-07.2007 · Cited by 56 · see citing works

Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology

Teaktong, T., Graham, A. J., COURT, J. A., Perry, R. H., Jaros, E., Johnson, M., Hall, R., & Perry, E. K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.015 · Cited by 56 · see citing works

Contribution of neural networks to Alzheimer disease's progression

Savioz, A., Leuba, G., Vallet, P. G., & Walzer, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.006 · Cited by 55 · see citing works

β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices

Kabogo, D., Rauw, G. A., Amritraj, A., Baker, G. B., & Kar, S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.009 · Cited by 55 · see citing works

Synaptic Retrogenesis and Amyloid-β in Alzheimer's Disease

Wasling, P., Daborg, J., Riebe, I., Andersson, M., Portelius, E., Blennow, K., Hanse, E., & Zetterberg, H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0918 · Cited by 53 · see citing works

Bilateral injections of βA(25–35)+IBO into the hippocampus disrupts acquisition of spatial learning in the rat

Dornan, W. A., Kang, D. E., McCampbell, A., & Kang, E. E. (1993) · Neuroreport · doi:10.1097/00001756-199311180-00018 · Cited by 51 · see citing works

Effects of Nicotine

Burn, J. H. (1968) · BMJ · doi:10.1136/bmj.1.5587.310-b · Cited by 50 · see citing works

Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice

Machová, E., Jakubík, J., Michal, P., Oksman, M., Iivonen, H., Tanila, H., & Doležal, V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.029 · Cited by 50 · see citing works

Aromatic residues at position 55 of rat α7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization

Gay, E. A., Giniatullin, R. A., Skorinkin, A., & Yakel, J. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149492 · Cited by 49 · see citing works

Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.

Ciccotosto, G., Tew, D., Drew, S., Smith, D. G., Johanssen, T., Lal, V., Lau, T., Perez, K., Curtain, C., Wade, J., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.018 · Cited by 48 · see citing works

Incubation of nerve endings with a physiological concentration of Aβ1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release

Bobich, J. A., Zheng, Q., & Campbell, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6305 · Cited by 46 · see citing works

Nicotine Enhances the Depressive Actions of Aβ1–40 on Long-Term Potentiation in the Rat Hippocampal CA1 Region In Vivo

Freir, D. B., & Herron, C. E. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00996.2002 · Cited by 46 · see citing works

Mg2+and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes

Wrighton, D. C., Baker, E. J., Chen, P. E., & Wyllie, D. J. A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143164 · Cited by 46 · see citing works

Memory performance is related to amyloid and tau pathology in the hippocampus

Reitz, C., Honig, L. S., Vonsattel, J. P., Tang, M.-X., & Mayeux, R. P. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154146 · Cited by 45 · see citing works

Unraveling in vivo Functions of Amyloid Precursor Protein: Insights from Knockout and Knockdown Studies

Sénéchal, Y., Larmet, Y., & Dev, K. K. (2006) · Neurodegenerative Diseases · doi:10.1159/000094772 · Cited by 44 · see citing works

The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy

Peña‐Ortega, F., Gutiérrez-Lerma, A. I., Quiroz‐Baez, R., & Arias, C. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359531 · Cited by 44 · see citing works

αv integrins mediate beta-amyloid induced inhibition of long-term potentiation

Wang, Q., Klyubin, I., Wright, S., Griswold-Prenner, I., Rowan, M. J., & Anwyl, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.018 · Cited by 42 · see citing works

Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease

Goto, Y., Niidome, T., Hongo, H., Akaike, A., Kihara, T., & Sugimoto, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.030 · Cited by 39 · see citing works

Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP

Welsby, P. J., Rowan, M. J., & Anwyl, R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.013 · Cited by 39 · see citing works

The α7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against β-amyloid1–42 toxicity in primary neuron-enriched cultures

Martin, S. E., de Fiebre, N. E. C., & de Fiebre, C. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.016 · Cited by 39 · see citing works

Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction

Yamazaki, Y., Hamaue, N., & Sumikawa, K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02935-9 · Cited by 39 · see citing works

Divergent effects of Aβ1–42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo

Szegedi, V., Juhász, G., Budai, D., & Penke, B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.014 · Cited by 38 · see citing works

α4β2 nicotinic acetylcholine receptors are required for the amyloid β protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo

Wu, M., He, Y., Guo, F., & Qi, J. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.06.005 · Cited by 30 · see citing works

Metabolic Brain Disease

(2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47778-9.50239-7 · Cited by 22 · see citing works

Glutamatergic synaptic depression by synthetic amyloid β‐peptide in the medial septum

Santos‐Torres, J., de la Fuente, A., Criado, J. M., Riolobos, A. S., Heredia, M., & Yajeya, J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21150 · Cited by 21 · see citing works

A brief, but repeated, swimming protocol is sufficient to overcome amyloid β‐protein inhibition of hippocampal long‐term potentiation

Li, S., Feig, L. A., & Hartley, D. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05760.x · Cited by 9 · see citing works

Pathogenesis of Alzheimer disease

Pavlović, D. M., Pavlovic, A. M., & Zugic, S. (2007) · Vojnosanitetski pregled · doi:10.2298/vsp0711765p · Cited by 8 · see citing works

Hippocampus in health and disease: An overview

Dhikav, V., & Anand, K. S. (2012) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.104323 · Cited by 603 · see citing works

S-Glutathionylation: From Molecular Mechanisms to Health Outcomes

Xiong, Y., Uys, J. D., Tew, K. D., & Townsend, D. M. (2011) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2010.3540 · Cited by 314 · see citing works

NMDA receptors in nervous system diseases

Zhou, Q., & Sheng, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.030 · Cited by 293 · see citing works

The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replication

Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Müller, V., Krishnan, R., Vabulas, R. M., Kretzschmar, H. A., Lindquist, S. L., Hartl, F. U., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.86 · Cited by 244 · see citing works

The roles of TNF in brain dysfunction and disease

Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 232 · see citing works

Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?

Esposito, Z., Belli, L., Toniolo, S., Sancesario, G., Bianconi, C., & Martorana, A. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12095 · Cited by 198 · see citing works

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

Goure, W. F., Krafft, G. A., Jerecic, J., & Hefti, F. (2014) · Alzheimer's Research &amp; Therapy · doi:10.1186/alzrt272 · Cited by 190 · see citing works

Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?

Martorana, A., Esposito, Z., & Koch, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00175.x · Cited by 174 · see citing works

Long-Term Potentiation at CA3–CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress

Kumar, A. (2011) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2011.00007 · Cited by 169 · see citing works

Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics

Bitner, R. S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.009 · Cited by 163 · see citing works

Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients

Koch, G., Lorenzo, F. D., Bonnı̀, S., Ponzo, V., Caltagirone, C., & Martorana, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120532 · Cited by 149 · see citing works

NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disorders

Zorumski, C. F., & Izumi, Y. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.011 · Cited by 145 · see citing works

Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease

Fisher, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07507.x · Cited by 140 · see citing works

The role of TGF-β superfamily signaling in neurological disorders

Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 126 · see citing works

Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?

Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129033 · Cited by 122 · see citing works

The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: Implications for Alzheimer's disease

Plácido, A. I., Pereira, C., Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S. M., Oliveira, C. R., & Moreira, P. I. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.003 · Cited by 118 · see citing works

Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory

Puzzo, D., Privitera, L., & Palmeri, A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.020 · Cited by 121 · see citing works

Robust amyloid clearance in a mouse model of Alzheimer’s disease provides novel insights into the mechanism of amyloid-β immunotherapy

Wang, A., Das, P., Switzer, R. C., Golde, T. E., & Jankowsky, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5077-10.2011 · Cited by 118 · see citing works

FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats

Asle‐Rousta, M., Kolahdooz, Z., Oryan, S., Ahmadiani, A., & Dargahi, L. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9979-6 · Cited by 112 · see citing works

Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer’s Disease: Dissociation between Somatosensory Cortex and Hippocampus

Crouzin, N., Baranger, K., Cavalier, M., Marchalant, Y., Cohen‐Solal, C., Roman, F. S., Khrestchatisky, M., Rivera, S., Feron, F. P., & Vignes, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074667 · Cited by 111 · see citing works

Region- and Age-Specific Changes in Glutamate Transport in the AβPP23 Mouse Model for Alzheimer's Disease

Schallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109 · see citing works

GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease

Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00167 · Cited by 105 · see citing works

Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow

Choi, Y. J., Chae, S., Kim, J. H., Barald, K. F., Park, J. Y., & Lee, S. (2013) · Scientific Reports · doi:10.1038/srep01921 · Cited by 101 · see citing works

Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances

Hu, N., Ondrejčák, T., & Rowan, M. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.013 · Cited by 99 · see citing works

The N-Methylated Peptide SEN304 Powerfully Inhibits Aβ(1–42) Toxicity by Perturbing Oligomer Formation

Amijee, H., Bate, C., Williams, A., Virdee, J. K., Jeggo, R., Spanswick, D. C., Scopes, D. I. C., Treherne, J. M., Mazzitelli, S., Chawner, R., et al. (2012) · Biochemistry · doi:10.1021/bi300415v · Cited by 70 · see citing works

Fyn, a Potential Target for Alzheimer's Disease

Yang, K., Belrose, J. C., Trepanier, C. H., Lei, G., Jackson, M. F., & MacDonald, J. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110353 · Cited by 66 · see citing works

Curcumin/Melatonin Hybrid 5-(4-Hydroxy-phenyl)-3-oxo-pentanoic Acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide Ameliorates AD-Like Pathology in the APP/PS1 Mouse Model

Gereñu, G., Liu, K., Chojnacki, J. E., Saathoff, J. M., Martínez‐Martín, P., Perry, G. L., Zhu, X., Lee, H., & Zhang, S. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00082 · Cited by 67 · see citing works

Cell adhesion molecules in Alzheimer's disease

Nielsen, H. M., & Wennström, M. (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19829 · Cited by 64 · see citing works

Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1‐40) administration in mice

Santos, V. V., Stark, R., Rial, D., Silva, H., Bayliss, J., Lemus, M., Davies, J., Cunha, R. A., Prediger, R., & Andrews, Z. (2017) · Journal of neuroendocrinology · doi:10.1111/jne.12476 · Cited by 58 · see citing works

Review of drugs for Alzheimer's disease

Sun (2012) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2012.v6.6.285 · Cited by 60 · see citing works

Homeostatic Disinhibition in the Aging Brain and Alzheimer's Disease

Gleichmann, M., Chow, V. W., & Mattson, M. P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101674 · Cited by 58 · see citing works

Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease

Wilkerson, J. R., Albanesi, J. P., & Huber, K. M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.035 · Cited by 57 · see citing works

PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments

Nicholls, R. E., Sontag, J.-M., Zhang, H., Staniszewski, A., Yan, S., Kim, C. Y., Yim, M., Woodruff, C. M., Arning, E., Wasek, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521018113 · Cited by 56 · see citing works

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

Krafft, G. A., Jerecı̀ć, J., Siemers, E., & Cline, E. N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.848215 · Cited by 51 · see citing works

Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain

Patel, A. N., & Jhamandas, J. H. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002134 · Cited by 51 · see citing works

High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1–42-induced Alzheimer's disease

Kong, L.-H., Yu, C.-C., Wang, Y., Shen, F., Wang, Y., Zhou, H., & Tang, L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238620 · Cited by 50 · see citing works

Selective Impairment of Some Forms of Synaptic Plasticity by Oligomeric Amyloid-β Peptide in the Mouse Hippocampus: Implication of Extrasynaptic NMDA Receptors

Kervern, M., Angeli, A., Nicole, O., Léveillé, F., Parent, B., Villette, V., Buisson, A., & Dutar, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120394 · Cited by 49 · see citing works

Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease

Simonyi, Á., He, Y., Sheng, W., Sun, A. Y., Wood, W. G., Weisman, G. A., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8107-7 · Cited by 49 · see citing works

Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer’s disease model

Pinz, M. P., dos Reis, A. S., Vogt, A. G., Krüger, R., Alves, D. A. C., Jessé, C. R., Roman, S. S., Soares, M. P., Wilhelm, E. A., & Luchese, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.049 · Cited by 49 · see citing works

CSF Tau Levels Influence Cortical Plasticity in Alzheimer's Disease Patients

Koch, G., Esposito, Z., Kusayanagi, H., Monteleone, F., Codecà, C., Lorenzo, F. D., Caltagirone, C., Bernardi, G., & Martorana, A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110116 · Cited by 49 · see citing works

Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients

Koch, G., Esposito, Z., Codecà, C., Mori, F., Kusayanagi, H., Monteleone, F., Lorenzo, F. D., Bernardi, G., & Martorana, A. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2010.10.033 · Cited by 49 · see citing works

Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities

Li, S., & Stern, A. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01589-5 · Cited by 46 · see citing works

Long-term Dantrolene Treatment Reduced Intraneuronal Amyloid in Aged Alzheimer Triple Transgenic Mice

Wu, Z., Yang, B., Liu, C., Liang, G., Liu, W., Pickup, S., Meng, Q., Tian, Y., Li, S., Eckenhoff, M. F., et al. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000075 · Cited by 46 · see citing works

Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo

Ondrejčák, T., Hu, N., Qi, Y., Klyubin, I. V., Corbett, G. T., Fraser, G. M., Perkinton, M. S., Walsh, D. M., Billinton, A., & Rowan, M. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.022 · Cited by 46 · see citing works

Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease

Zhao, R. J., Fowler, S., Chiang, A. C. A., Ji, D., & Jankowsky, J. L. (2014) · Hippocampus · doi:10.1002/hipo.22283 · Cited by 42 · see citing works

Integrating Cytosolic Phospholipase A2 with Oxidative/Nitrosative Signaling Pathways in Neurons: A Novel Therapeutic Strategy for AD

Sun, G. Y., He, Y., Chuang, D. Y., Lee, J. C., Gu, Z., Simonyi, Á., & Sun, A. Y. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8261-1 · Cited by 44 · see citing works

Developmental profile of SK2 channel expression and function in CA1 neurons

Ballesteros‐Merino, C., Lin, M. T., Wu, W., Ferrándiz‐Huertas, C., Cabañero, M. J., Watanabe, M., Fukazawa, Y., Shigemoto, R., Maylie, J., Adelman, J. P., et al. (2011) · Hippocampus · doi:10.1002/hipo.20986 · Cited by 43 · see citing works

Alzheimer’s Disease and Protein Kinases

Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 43 · see citing works

Electrochemical aptamer-based nanobiosensors for diagnosing Alzheimer's disease: A review

Negahdary, M., & Angnes, L. (2022) · Biomaterials Advances · doi:10.1016/j.msec.2022.112689 · Cited by 42 · see citing works

Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage

Földes, A., Kádár, K., Kerémi, B., Zsembery, Á., Gyires, K., Zádori, Z., & Varga, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160121115210 · Cited by 40 · see citing works

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

Chakravarthy, M., Chen, S., Dodd, P. R., & Veedu, R. N. (2017) · Theranostics · doi:10.7150/thno.21529 · Cited by 38 · see citing works

Developmental synaptic regulator, TWEAK/Fn14 signaling, is a determinant of synaptic function in models of stroke and neurodegeneration

Nagy, D., Ennis, K. A., Wei, R., Su, S. C., Hinckley, C. A., Gu, R.-F., Gao, B., Massol, R., Ehrenfels, C., Jandreski, L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001679118 · Cited by 38 · see citing works

Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers

Song, J., Cho, E., Lee, H., Lee, S., Kim, S., & Kim, J. (2025) · Biosensors · doi:10.3390/bios15020102 · Cited by 37 · see citing works

Memory defect induced by beta-amyloid plus glutamate receptor agonist is alleviated by catalpol and donepezil through different mechanisms

Xia, Z., Zhang, R., Wu, P., Xia, Z., & Hu, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.008 · Cited by 36 · see citing works

Distinct Transcriptome Expression of the Temporal Cortex of the Primate Microcebus murinus during Brain Aging versus Alzheimer's Disease-Like Pathology

Rassoul, R. A., Alves, S., Pantesco, V., Vos, J. D., Michel, B. F., Perret, M., Mestre‐Francés, N., Verdier, J., & Devau, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012770 · Cited by 35 · see citing works

Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampus

Ondrejčák, T., Wang, Q., Kew, J. N. C., Virley, D. J., Upton, N., Anwyl, R., & Rowan, M. J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.008 · Cited by 35 · see citing works

Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression

Buizza, L., Prandelli, C., Bonini, S. A., Delbarba, A., Cenini, G., Lanni, C., Buoso, E., Racchi, M., Govoni, S. M., Memo, M., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.13 · Cited by 34 · see citing works

Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration

Laursen, B., Mørk, A., Plath, N., Kristiansen, U., & Bastlund, J. F. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.055 · Cited by 33 · see citing works

The modulatory role of phloretin in Aβ25–35 induced sporadic Alzheimer’s disease in rat model

Ghumatkar, P. J., Patil, S. P., Peshattiwar, V., Vijaykumar, T., Dighe, V. D., Vanage, G. R., & Sathaye, S. S. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1588-z · Cited by 34 · see citing works

The 5‐hydroxytryptamine4receptor enables differentiation of informational content and encoding in the hippocampus

Twarkowski, H., Hagena, H., & Manahan‐Vaughan, D. (2016) · Hippocampus · doi:10.1002/hipo.22569 · Cited by 33 · see citing works

Pathway-Specific Alteration of Synaptic Plasticity in Tg2576 Mice

Jung, J. H., An, K., Kwon, O. B., Kim, H.-S., & Kim, J. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0077-8 · Cited by 33 · see citing works

Neurogranin restores amyloid β-mediated synaptic transmission and long-term potentiation deficits

Kaleka, K. S., & Gerges, N. Z. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.12.013 · Cited by 33 · see citing works

Roles and Mechanisms of the Protein Quality Control System in Alzheimer’s Disease

Liu, Y., Ding, R., Xu, Z., Xue, Y., Zhang, D., Zhang, Y., Li, W., & Li, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010345 · Cited by 32 · see citing works

Hippocampal synaptic activity, pattern separation and episodic-like memory: implications for mouse models of Alzheimer's disease pathology

Palmer, A., & Good, M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390902 · Cited by 34 · see citing works

Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer’s Disease

Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 29 · see citing works

Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches

Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31 · see citing works

Amyloid Beta Peptide Slows Down Sensory-Induced Hippocampal Oscillations

Peña‐Ortega, F., & Bernal‐Pedraza, R. (2012) · International Journal of Peptides · doi:10.1155/2012/236289 · Cited by 29 · see citing works

Serotonergic neuromodulation of synaptic plasticity

Higa, G. S. V., Viana, F. J. C., Francis-Oliveira, J., Cruvinel, E., Franchin, T. S., Marcourakis, T., Ulrich, H., & De Pasquale, R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110036 · Cited by 29 · see citing works

Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid

Asam, K. R., Staniszewski, A., Zhang, H., Melideo, S. L., Mazzeo, A., Voronkov, M. V., Huber, K. L., Pérez, E., Stock, M. B., Stock, J. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189413 · Cited by 28 · see citing works

Modulation of Amyloid β-Induced Microglia Activation and Neuronal Cell Death by Curcumin and Analogues

Lorenzi, E. D., Franceschini, D., Contardi, C., Martino, R. M. C. D., Seghetti, F., Serra, M., Bisceglia, F., Pagetta, A., Zusso, M., & Belluti, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084381 · Cited by 28 · see citing works

Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer’s Disease: Common Pathologies Potentiated by Altered Zinc Homeostasis

Portbury, S. D., & Adlard, P. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143048 · Cited by 26 · see citing works

Amyloid Beta Peptides Differentially Affect Hippocampal Theta Rhythms In Vitro

Gutiérrez-Lerma, A. I., Ordaz, B., & Peña‐Ortega, F. (2013) · International Journal of Peptides · doi:10.1155/2013/328140 · Cited by 26 · see citing works

Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo

Klyubin, I. V., Ondrejčák, T., Hayes, J., Cullen, W. K., Mably, A. J., Walsh, D. M., & Rowan, M. J. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0147 · Cited by 26 · see citing works

How dependent is synaptic plasticity on microglial phenotype?

Jones, R. S., & Lynch, M. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.012 · Cited by 24 · see citing works

Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer’s disease

Schreurs, B. G., Smith‐Bell, C. A., & Lemieux, S. K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.015 · Cited by 24 · see citing works

G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channel Activation by the p75 Neurotrophin Receptor Is Required for Amyloid β Toxicity

May, L. M., Anggono, V., Gooch, H. M., Jang, S. E., Matusica, D., Kerbler, G. M., Meunier, F. A., Sah, P., & Coulson, E. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00455 · Cited by 22 · see citing works

The Role of Activity in Synaptic Degeneration in a Protein Misfolding Disease, Prion Disease

Caleo, M., Restani, L., Vannini, E., Šišková, Z., Al-Malki, H., Morgan, R. S. M., O'Connor, V. M., & Perry, V. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041182 · Cited by 21 · see citing works

Dihydroxybenzoic Acid Isomers Differentially Dissociate Soluble Biotinyl-Aβ(1–42) Oligomers

LeVine, H., Lampe, L., Abdelmoti, L. G., & Augelli‐Szafran, C. E. (2011) · Biochemistry · doi:10.1021/bi201288x · Cited by 22 · see citing works

Learning-Related Hippocampal Long-Term Potentiation and Long-Term Depression

Manahan‐Vaughan, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21104-8 · Cited by 21 · see citing works

Downregulation of autophagy by 12/15Lipoxygenase worsens the phenotype of an Alzheimer’s disease mouse model with plaques, tangles, and memory impairments

Li, J.-G., Chu, J., & Praticò, D. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0268-1 · Cited by 21 · see citing works

Chronic Monoarthritis Pain Accelerates the Processes of Cognitive Impairment and Increases the NMDAR Subunits NR2B in CA3 of Hippocampus from 5-month-old Transgenic APP/PS1 Mice

Gong, W.-Y., Wang, R., Liu, Y., Jin, H., Zhao, Z., Wang, Y., Li, H., Zhang, X., & Ni, J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00123 · Cited by 23 · see citing works

Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus

Zappettini, S., Grilli, M., Olivero, G., Mura, E., Preda, S., Govoni, S. M., Salamone, A., & Marchi, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00146 · Cited by 20 · see citing works

Orally bioavailable small molecule drug protects memory in Alzheimer's disease models

O‘Hare, E., Scopes, D. I. C., Kim, E., Palmer, P., Jones, M. G., Whyment, A. D., Spanswick, D. C., Amijee, H., Nerou, E., McMahon, B., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.016 · Cited by 19 · see citing works

Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice

Vargas-Caballero, M., Denk, F., Wobst, H. J., Arch, E., Pegasiou, C.-M., Oliver, P. L., Shipton, O. A., Paulsen, O., & Wade-Martins, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00201 · Cited by 18 · see citing works

Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ

Shipton, O. A., Tang, C. S., Paulsen, O., & Vargas‐Caballero, M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01350-7 · Cited by 17 · see citing works

Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer’s disease

Liang, J., Kulasiri, D., & Samarasinghe, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182743 · Cited by 18 · see citing works

Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer’s Disease

Liu, X.-J., Wei, J., Shang, Y., Huang, H., & Lao, F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161111 · Cited by 18 · see citing works

Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity

Scopes, D., O‘Hare, E., Jeggo, R., Whyment, A. D., Spanswick, D. C., Kim, E.-M., Gannon, J., Amijee, H., & Treherne, J. M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01973.x · Cited by 17 · see citing works

The Density of Group I mGlu5 Receptors Is Reduced along the Neuronal Surface of Hippocampal Cells in a Mouse Model of Alzheimer’s Disease

Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Albasanz, J. L., Martı́n, M., Moreno‐Martínez, A. E., Fukazawa, Y., & Luján, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115867 · Cited by 16 · see citing works

Positron Emission Tomography Molecular Imaging in Late-Life Depression

Hirao, K., & Smith, G. S. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516540 · Cited by 15 · see citing works

Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study

the German AgeGain study group, Wolf, D. G. F., Tüscher, O., Teipel, S. J., Mierau, A., Strüder, H. K., Drzezga, A. E., Baier, B., Binder, H., & Fellgiebel, A. (2018) · Trials · doi:10.1186/s13063-018-2688-2 · Cited by 16 · see citing works

Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease

O‘Hare, E., Scopes, D. I. C., Kim, E., Palmer, P., Spanswick, D. C., McMahon, B., Amijee, H., Nerou, E., Treherne, J. M., & Jeggo, R. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000886 · Cited by 16 · see citing works

Regulation of cerebral blood flow in the hippocampus by neuronal activation through the perforant path: Relationship between hippocampal blood flow and neuronal plasticity

Hamadate, N., Yamaguchi, T., Sugawara, A., Tsujimatsu, A., Izumi, T., Yoshida, T., Ohmura, Y., & Yoshioka, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.008 · Cited by 15 · see citing works

Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations

Araya, J., Bello, F., Shivashankar, G., Neira, D., Duran-Aniotz, C. A., Acosta, M. L., Escobar, M.-J., Hetz, C. A., Chacón, M., & Palacios, A. G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201195 · Cited by 13 · see citing works

Early Molecular and Synaptic Dysfunctions In the Prodromal Stages of Alzheimer‘s Disease: Focus on Tnf-α and Il-1β

Cavanagh, C., Colby-Milley, J., Farso, M. C., Krantic, S. M., & Quirion, R. (2011) · Future Neurology · doi:10.2217/fnl.11.50 · Cited by 13 · see citing works

Physical Stress Induced Reduction of Proliferating Cells and Differentiated Neuroblasts Is Ameliorated by Fermented Laminaria japonica Extract Treatment

Jung, H. Y., Kim, W., Kwon, H. J., Yoo, D. Y., Nam, S. M., Hahn, K. R., Yi, S. S., Choi, J. H., Kim, D. W., Yoon, Y. S., et al. (2020) · Marine Drugs · doi:10.3390/md18120587 · Cited by 13 · see citing works

mGluR-dependent plasticity in rodent models of Alzheimer’s disease

Valdivia, G., Ardiles, Á. O., Idowu, A., Salazar, C., Lee, H., Gallagher, M., Palacios, A. G., & Kirkwood, A. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1123294 · Cited by 11 · see citing works

An evaluation study on screening, partial purification, and characterization of proteins and antioxidant peptides from two varieties of Clitoria Ternatea

Suresh, H., Ganapathy, M., Abinaya, K., Sakthivelu, M., Thirumavalavan, M., Anbu, P., & Pachaiappan, R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138312 · Cited by 11 · see citing works

Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties

Remya, C., Dileep, K. V., Variyar, E. J., Zhang, K. Y. J., Omkumar, R. V., & Sadasivan, C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.148 · Cited by 11 · see citing works

Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease

Ma, T., & Klann, E. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07506.x · Cited by 131 · see citing works

A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain

Li, S., & Selkoe, D. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15007 · Cited by 264 · see citing works

O2‐02–02: Soluble amyloid β‐protein dimers isolated directly from Alzheimer's disease patients potently impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T., García-Muñoz, A., Shepardson, N. E., Smith, I. M., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.314 · Cited by 2 · see citing works

Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease

Benarroch, E. E. (2018) · Neurology · doi:10.1212/wnl.0000000000005807 · Cited by 134 · see citing works

Maladie d’Alzheimer, peptide β-amyloïde et synapses

Hémar, A., & Mulle, C. (2011) · médecine/sciences · doi:10.1051/medsci/2011278015 · Cited by 8 · see citing works